Literature DB >> 30883391

Phosphate, the forgotten mineral in hypertension.

Han-Kyul Kim1,2, Masaki Mizuno2,3, Wanpen Vongpatanasin1,2,4.   

Abstract

PURPOSE OF REVIEW: The purpose of this study is to review the current literature related to the role of inorganic phosphate in the pathogenesis of hypertension. RECENT
FINDINGS: An increasing number of publications have revealed a detrimental role of inorganic phosphate, which is commonly used as a flavor enhancer or preservative in the processed food, in promoting hypertension in otherwise healthy individuals. Animal experimental data indicate that dietary phosphate excess engages multiple mechanisms that promote hypertension, including overactivation of the sympathetic nervous system, increased vascular stiffness, impaired endothelium-dependent vasodilation, as well as increased renal sodium absorption or renal injury. These effects may be explained by direct effects of high extracellular phosphate levels or increase in phosphaturic hormones such as fibroblast growth factor 23, or downregulation of klotho, a transmembrane protein expressed in multiple organs which possess antiaging property.
SUMMARY: Dietary phosphate, particularly inorganic phosphate, is an emerging risk factor for hypertension which is ubiquitous in the western diet. Large randomized clinical trials are needed to determine if lowering dietary phosphate content constitutes an effective nonpharmacologic intervention for prevention and treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30883391      PMCID: PMC6692179          DOI: 10.1097/MNH.0000000000000503

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  46 in total

Review 1.  FGF23 and Nutritional Metabolism.

Authors:  Lindsay R Pool; Myles Wolf
Journal:  Annu Rev Nutr       Date:  2017-07-17       Impact factor: 11.848

2.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

3.  Prognostic Value of Masked Uncontrolled Hypertension.

Authors:  Sante D Pierdomenico; Anna M Pierdomenico; Francesca Coccina; Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Iddo Z Ben-Dov; Wanpen Vongpatanasin; José R Banegas; Luis M Ruilope; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

4.  Serum phosphorus is related to left ventricular remodeling independent of renal function in hospitalized patients with chronic kidney disease.

Authors:  Jun Zou; Yi Yu; Ping Wu; Fu-Jun Lin; Yao Yao; Yun Xie; Geng-Ru Jiang
Journal:  Int J Cardiol       Date:  2016-06-26       Impact factor: 4.164

Review 5.  Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.

Authors:  Shunsuke Yamada; Cecilia M Giachelli
Journal:  Bone       Date:  2016-11-12       Impact factor: 4.398

Review 6.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

7.  Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults.

Authors:  Rajan K Patel; Panniyammakal Jeemon; Kathryn K Stevens; Linsay Mccallum; Claire E Hastie; Andreas Schneider; Alan G Jardine; Patrick B Mark; Sandosh Padmanabhan
Journal:  J Hypertens       Date:  2015-10       Impact factor: 4.844

8.  Dietary Sources of Phosphorus among Adults in the United States: Results from NHANES 2001-2014.

Authors:  Scott T McClure; Alex R Chang; Elizabeth Selvin; Casey M Rebholz; Lawrence J Appel
Journal:  Nutrients       Date:  2017-01-30       Impact factor: 5.717

9.  Phosphate control in reducing FGF23 levels in hemodialysis patients.

Authors:  Cristian Rodelo-Haad; Maria E Rodríguez-Ortiz; Alejandro Martin-Malo; M Victoria Pendon-Ruiz de Mier; M Luisa Agüera; Juan R Muñoz-Castañeda; Sagrario Soriano; Francisco Caravaca; M Antonia Alvarez-Lara; Arnold Felsenfeld; Pedro Aljama; Mariano Rodriguez
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

10.  Serum phosphate levels are related to all-cause, cardiovascular and COPD mortality in men.

Authors:  Natalia Campos-Obando; Lies Lahousse; Guy Brusselle; Bruno H Stricker; Albert Hofman; Oscar H Franco; André G Uitterlinden; M Carola Zillikens
Journal:  Eur J Epidemiol       Date:  2018-05-15       Impact factor: 8.082

View more
  6 in total

Review 1.  Phosphate Is a Cardiovascular Toxin.

Authors:  Maren Leifheit-Nestler; Isabel Vogt; Dieter Haffner; Beatrice Richter
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Phosphate and Cellular Senescence.

Authors:  Ming Chang Hu; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na+ transport in Dahl SS rats.

Authors:  Olha Kravtsova; Ruslan Bohovyk; Vladislav Levchenko; Oleg Palygin; Christine A Klemens; Timo Rieg; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-25

4.  Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.

Authors:  Anders Nordholm; Søren Egstrand; Eva Gravesen; Maria L Mace; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Pflugers Arch       Date:  2019-06-24       Impact factor: 3.657

Review 5.  Should We Consider the Cardiovascular System While Evaluating CKD-MBD?

Authors:  Merita Rroji; Andreja Figurek; Goce Spasovski
Journal:  Toxins (Basel)       Date:  2020-02-25       Impact factor: 4.546

6.  Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients.

Authors:  Jinwoo Jung; Haekyung Jeon-Slaughter; Hang Nguyen; Jiten Patel; Kamalanathan K Sambandam; Shani Shastri; Peter Noel Van Buren
Journal:  BMC Nephrol       Date:  2022-08-23       Impact factor: 2.585

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.